Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
NeuroBo Pharmaceuticals (NRBO)
NASDAQ:NRBO
RESEARCH TOOLSreports
Holding NRBO?
Track your performance easily
NRBO Stock Chart & Stats
Day’s Range$2.32 - $2.44
52-Week Range― - ―
Previous Close$2.35
Volume13.07K
Average Volume (3M)N/A
Market Cap
$22.14M
Enterprise ValueN/A
Total Cash (Recent Filing)N/A
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)―
BetaN/A
Next Earnings
Mar 27, 2025EPS Estimate
-$0.49Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)N/A
Shares Outstanding8,616,010
10 Day Avg. Volume41,394
30 Day Avg. Volume38,590
Standard Deviation0.25
R-Squared0.00300
Alpha-0.07
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)1.60
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)-0.90
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
$10.00Price Target Upside323.73% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering1
NeuroBo Pharmaceuticals News
PremiumCompany Announcements
NeuroBo Pharmaceuticals Reveals Promising Therapeutic Developments
PremiumCompany Announcements
NeuroBo Pharmaceuticals Rebrands Amidst Strategic Changes
PremiumCompany Announcements
NeuroBo Pharmaceuticals Completes Phase 2a Trial for MASH Drug
PremiumCompany Announcements
NeuroBo Pharmaceuticals Unveils Updated Corporate Presentation
PremiumCompany Announcements
NeuroBo’s DA-1726 Shows Promise in Obesity Trial Phase 1Ownership Overview
64.23% Insiders
1.02% Mutual Funds
10.88% Other Institutional Investors
23.11% Public Companies and
Individual Investors
Risk Analysis
Main Risk Category
Tech & InnovationRisks related to the company’s reliance on technology and ability to make innovative products
NRBO FAQ
What was NeuroBo Pharmaceuticals’s price range in the past 12 months?
Currently, no data Available
What is NeuroBo Pharmaceuticals’s market cap?
Currently, no data Available
When is NeuroBo Pharmaceuticals’s upcoming earnings report date?
NeuroBo Pharmaceuticals’s upcoming earnings report date is Mar 27, 2025 which is in 94 days.
How were NeuroBo Pharmaceuticals’s earnings last quarter?
NeuroBo Pharmaceuticals released its earnings results on Nov 07, 2024. The company reported -$0.55 earnings per share for the quarter, beating the consensus estimate of -$0.82 by $0.27.
Is NeuroBo Pharmaceuticals overvalued?
According to Wall Street analysts NeuroBo Pharmaceuticals’s price is currently Undervalued.
Does NeuroBo Pharmaceuticals pay dividends?
NeuroBo Pharmaceuticals does not currently pay dividends.
What is NeuroBo Pharmaceuticals’s EPS estimate?
NeuroBo Pharmaceuticals’s EPS estimate is -$0.49.
How many shares outstanding does NeuroBo Pharmaceuticals have?
Currently, no data Available
What happened to NeuroBo Pharmaceuticals’s price movement after its last earnings report?
NeuroBo Pharmaceuticals reported an EPS of -$0.55 in its last earnings report, beating expectations of -$0.82. Following the earnings report the stock price went down -2.19%.
Which hedge fund is a major shareholder of NeuroBo Pharmaceuticals?
Currently, no hedge funds are holding shares in NRBO
---
NeuroBo Pharmaceuticals Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$10.00 (323.73% Upside)
$10.00 (323.73% Upside)
Blogger Sentiment
Bullish
NRBO Sentiment 100%
Sector Average 71%
Sector Average 71%
Insider Transactions
Sold Shares
Worth $1.5K over
the Last 3 Months
the Last 3 Months
Technicals
SMA
Negative
20 days / 200 days
Momentum
-27.75%
12-Months-Change
Fundamentals
Return on Equity
-160.76%
Trailing 12-Months
Asset Growth
-16.19%
Trailing 12-Months
Company Description
NeuroBo Pharmaceuticals
NeuroBo Pharmaceuticals, Inc. is a clinical-stage biotechnology company focused on developing novel pharmaceuticals to treat neurodegenerative disorders. The company was founded on October 30, 2014 and is headquartered in Boston, MA.
---
NRBO Stock 12 Month Forecast
Average Price Target
$10.00
▲(323.73% Upside)
Technical Analysis
Best Analysts Covering NRBO
1 Year
1 Year Success Rate
0/4 ratings generated profit
1 Year Average Return
-26.32%
reiterated a buy rating last month
Copying Jason McCarthy's trades and holding each position for 1 Year would result in 0.00% of your transactions generating a profit, with an average return of -26.32% per trade.
---